Real-World Outcomes

Research in Review

High Cost of Care for Older Patients With Brain Tumors at EOL

06/23/2017

JCP Editors

Hospital-based end-of-life (EOL) care for older patients with malignant brain tumors is associated with over $16,000 in expenses per patient, according to a research letter published in JAMA Oncology (published...

...

06/23/2017

Journal of Clinical Pathways

Research in Review

Oncology Rapid-Learning Systems Informed by Patient Perspectives

06/14/2017

JCP Editors

Perceptions of patients with cancer regarding secondary data use is essential to informing the implementation of oncology learning systems, according to research published in the Journal of Clinical Oncology...

...

06/14/2017

Journal of Clinical Pathways

Research in Review

Pazopanib Cost-Effective for Patients With Renal Cell Carcinoma

03/28/2017

JCP Editors

Medicare patients with advanced renal cell carcinoma benefit from lower costs and hospital admissions if treated with pazopanib rather than sunitinib, according to research presented at the AMCP Managed Care &...

...

03/28/2017

Journal of Clinical Pathways

Research in Review

Study: Newer NSCLC Therapies Have Limited Real-World Survival Benefit, High Costs

02/14/2017

JCP Editors

Therapies recently approved to treat advanced-stage non-small cell lung cancer (NSCLC) confer an average of 1.5-month survival increase and an $8,000 increase in outpatient spending per patient, according to a study...

...

02/14/2017

Journal of Clinical Pathways